Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

Syringic Acid Ameliorates Bleomycin Induced Pulmonary Inflammation and Fibrosis in Rats via Maintenance of Endogenous Antioxidants and Downregulation of Pro-Inflammatory Markers

1★, 2★ Corresponding author

  1. 1Department of Pharmacology, School of Allied and Healthcare Sciences, Malla Reddy University, Hyderabad, Telangana, INDIA.
  2. 2Department of Pharmacology, School of Pharmacy, KPJ Healthcare University College, Nilai, MALAYSIA.

CORRESPONDENCE

Bhupatiraju VS Lakshmi

Department of Pharmacology, School of Allied and Healthcare Sciences, Malla Reddy University, Hyderabad, Telangana, INDIA.

drbvslakshmi@allareddyuniversity.ac.in

Received: 21-10-2024; Accepted: 17-02-2025.

Volume 17, Issue 2 · pp. 532-542 · 2025 · DOI: 10.5530/pres.20251990

ABSTRACT

Chronic administration of Bleomycin (BLM), a chemotherapeutic drug, has been linked to Idiopathic Pulmonary Fibrosis (IPF). It has been observed that syringic acid, a phenolic compound, has antiapoptotic, anti-inflammatory and antioxidant properties. To assess syringic acid's therapeutic potential against lung fibrosis caused by BLM and determine potential mechanism of action. Sprague-Dawley rats were inducted into IPF after receiving 7.5 IU/kg of BLM intratracheally. Syringic acid (50 mg/kg, p.o.) was administered to rats for 14 days, after which different parameters in lung and Bronchoalveolar Lavage Fluid (BALF) were measured. Altered BALF differential cell counts, elevated lung index, hydroxyproline, NO, MDA levels and reduction in GSH, GPx, SOD and CAT in group receiving BLM were evidence of pulmonary toxicity. Administering 50 mg/kg of syringic acid significantly reduced (p<0.001) the changes brought about by BLM. The expression of TNF-α was greatly reduced by syringic acid when it was stimulated by BLM. The BLM-treated group's histological analysis revealed significant lung damage with alveolar septal thickening, interstitial infiltration, collapsing alveolar gaps and an elevated Szapiel score. Syringic acid lessened these effects. Syringic acid group (p<0.01) markedly reduced Szapiel score, collagen deposition, lung edema and fibrotic alterations. It also inhibited infiltration of myofibroblasts and inflammatory cells, primarily macrophages and lymphocytes. This, in turn, improves control of oxidant and pro-inflammatory markers (TNF-α) to decrease collagen deposition during pulmonary fibrosis. Finally, it is concluded that Syringic acid can protect the lung against BLM-induced pulmonary oxidative stress, inflammation and fibrosis.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Lakshmi, B. V., & Bethala, K. V. (2025). Syringic Acid Ameliorates Bleomycin Induced Pulmonary Inflammation and Fibrosis in Rats via Maintenance of Endogenous Antioxidants and Downregulation of Pro-Inflammatory Markers. Pharmacognosy Research, 17(2), 532-542. https://doi.org/10.5530/pres.20251990

    Copyright and licence

    © 2025 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0